핵의학

본문글자크기
  • [Clin Nucl Med.] Determination of Parkinson Disease Laterality After Deep Brain Stimulation Using 123I FP-CIT SPECT.

    [Clin Nucl Med.] Determination of Parkinson Disease Laterality After Deep Brain Stimulation Using 123I FP-CIT SPECT.

    서울대 / 박혜란, 임형준*, 백선하*

  • 출처
    Clin Nucl Med.
  • 등재일
    2020 Apr
  • 저널이슈번호
    45(4):e178-e184. doi: 10.1097/RLU.0000000000002955.
  • 내용

    바로가기  >

    Abstract
    INTRODUCTION:
    Symptom laterality is one of the main characteristics of Parkinson disease (PD) and reported to be associated with motor and nonmotor symptom severity and prognosis. This study aimed to evaluate the changes of laterality after deep brain stimulation (DBS) and the association between dopamine transporter SPECT using I FP-CIT (DAT SPECT) and symptom laterality in PD before and after DBS.

    METHODS:
    Nineteen patients with PD who received bilateral subthalamic nucleus DBS were enrolled. The clinical scores including Unified Parkinson Disease Rating Scale (UPDRS) and Hoehn and Yahr were evaluated at baseline, 6 months, and 1 year after DBS. Also, the patients underwent DAT SPECT before and 6 months and 1 year after DBS. Symptom and DAT laterality indices were determined based on the UPDRS part 3 and DAT SPECT, respectively. The association between DAT and symptom laterality was assessed at baseline and 6 months and 1 year after DBS.

    RESULTS:
    At baseline, 11, 6, and 2 among 19 patients had left-side-dominant, right-side-dominant, and symmetric motor symptom, respectively. Among 19 patients, there were 10 patients who showed changed symptom laterality within 1 year after DBS. The agreement between symptom laterality and DAT laterality was good to excellent at baseline and 6 months and 1 year after DBS (weighted κ = 0.742, 0.736, and 0.813). Furthermore, symptom and DAT laterality indices showed significant correlation at baseline (r = 0.542, P = 0.02), 6 months (r = 0.579, P = 0.01), and 1 year after DBS (r = 0.689, P = 0.02). Symptom laterality could be determined by DAT laterality index with areas under curve of 0.833 (P = 0.045), 0.982 (P < 0.001), and 1.000 (P < 0.001) at baseline and 6 and 12 months after DBS, respectively.

    CONCLUSIONS:
    The symptom laterality could be altered after DBS and was well correlated with laterality evaluated by DAT SPECT. An objective evaluation of laterality using DAT SPECT would be helpful for the management of patients with PD especially for adjusting the DBS programming for fine balancing of the asymmetric symptom after DBS. The large-scale study is warranted for validation of this result.

     


    Author information

    Park HR1, Ha S2,3, Lee DS3,4, Im HJ4, Paek SH5,6.
    1
    From the Department of Neurosurgery, Soonchunhyang University Seoul Hospital.
    2
    Division of Nuclear Medicine, Department of Radiology, Seoul St Mary's Hospital, The Catholic University of Korea.
    3
    Department of Nuclear Medicine, Seoul National University College of Medicine.
    4
    Graduate School of Convergence Science and Technology, Seoul National University.
    5
    Department of Neurosurgery, Clinical Research Institute, Seoul National University Hospital.
    6
    Hypoxia/Ischemia Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

  • 연구소개
    뇌심부자극술을 받은 파킨슨병 환자에서 뇌 도파민전달체 단일광자방출단층촬영(123I FP-CIT SPECT) 검사의 유용성을 규명한 연구결과입니다. 연구진은 뇌심부자극술 후 파킨슨병 증상의 비대칭성이 변할 수 있음을 밝혔고, 뇌심부자극술 전과 후 모두 증상과 영상검사로 측정한 비대칭성이 유의미한 연관성을 보인다는 것을 확인하여 영상을 통한 정밀한 비대칭성 증상 조절의 가능성을 제시하였습니다.
  • 덧글달기
    덧글달기
       IP : 44.192.75.131

    등록